UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
This opening covers the key components of an emergency budget, such as housing, food, healthcare, debt service, and savings.
24,022 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Investors often chase eye-popping targets, but can Nvidia stock truly double in 12 months? This article breaks down t...
Beachbody's 2025 earnings shed light on how fitness brands monetize digital subscriptions, gear, and licensing. This ...
When mining stocks fall, investors want to know the why and what next. This guide breaks down the drivers behind hecl...
CoreWeave surged after its IPO, then pulled back dramatically. This guide explains what happened, what the company do...
Tech ETFs offer fast access to the U.S. tech sector, but costs and portfolio makeup vary. This guide breaks down the ...
CoreWeave sits at the center of the AI compute boom, offering scalable GPU capacity. This article breaks down the bul...
Major U.S. carriers push lawmakers to fund DHS and guarantee wages for frontline workers amid a partial government sh...
Three forces—higher mortgage rates, tighter consumer budgets, and rising build costs—are shaping housing stocks under...
NVIDIA forecasts $1 trillion in AI hardware orders through 2027, highlighting the scale of the AI buildout and its im...
Real estate ETFs give you exposure to property markets without being a landlord. This guide compares REET and VNQ, fo...
Holding a long-term view can unlock the power of compounding with high-quality leaders and durable business moats. Th...